a16z | Implementation, Data, Impact of Healthcare AI with Julie and Vijay @a16z | Uploaded September 2024 | Updated October 2024, 42 minutes ago.
In this episode, Julie Yoo and Vijay Pande dive into the potential and challenges of implementing AI in healthcare. They revisit the grand challenges discussed in Part 1 of this conversation, Grand Challenges in Healthcare AI, and address new questions that have emerged, focusing on three main areas: the cost of healthcare and AI implementation, the data landscape for AI training, and patient experience.
Topics covered:
00:00 - Intro
00:03 - Overview of three clusters of Part 1 questions: cost, data, and patient experience
00:30 - Vijay Pande discusses AI's potential to lower healthcare costs
03:00 - Julie Yoo examines the impact of AI on cost structure and labor
06:39 - Challenges in reducing healthcare costs in America
08:15 - The role of AI in shifting from sick care to preventative care
12:00 - Financial incentives and barriers to AI adoption among clinicians
15:39 - Emotional and practical aspects driving AI adoption in healthcare
19:42 - The importance of data sharing and the role of AI in healthcare innovation
22:36 - The data advantage (or lack thereof) of legacy healthcare companies
24:00 - Balancing AI-driven recommendations with clinician expertise
27:00 - The role of AI in enhancing patient experience through choice and automation
30:00 - Long-term vision for AI in personalized and preventative healthcare
Resources:
Find Julie Yoo on Twitter: https://x.com/julieyoo
Find Vijay Pande on Twitter: https://x.com/vijaypande
Learn more about a16z Bio+Health: a16z.com/bio-health
Stay Updated:
Find a16z Bio+Health on LinkedIn: linkedin.com/showcase/a16z-bio-health
Find a16z Bio+Health on X: https://x.com/a16zBioHealth
Subscribe on your favorite podcast app: a16z.com/podcasts/raising-health
Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
In this episode, Julie Yoo and Vijay Pande dive into the potential and challenges of implementing AI in healthcare. They revisit the grand challenges discussed in Part 1 of this conversation, Grand Challenges in Healthcare AI, and address new questions that have emerged, focusing on three main areas: the cost of healthcare and AI implementation, the data landscape for AI training, and patient experience.
Topics covered:
00:00 - Intro
00:03 - Overview of three clusters of Part 1 questions: cost, data, and patient experience
00:30 - Vijay Pande discusses AI's potential to lower healthcare costs
03:00 - Julie Yoo examines the impact of AI on cost structure and labor
06:39 - Challenges in reducing healthcare costs in America
08:15 - The role of AI in shifting from sick care to preventative care
12:00 - Financial incentives and barriers to AI adoption among clinicians
15:39 - Emotional and practical aspects driving AI adoption in healthcare
19:42 - The importance of data sharing and the role of AI in healthcare innovation
22:36 - The data advantage (or lack thereof) of legacy healthcare companies
24:00 - Balancing AI-driven recommendations with clinician expertise
27:00 - The role of AI in enhancing patient experience through choice and automation
30:00 - Long-term vision for AI in personalized and preventative healthcare
Resources:
Find Julie Yoo on Twitter: https://x.com/julieyoo
Find Vijay Pande on Twitter: https://x.com/vijaypande
Learn more about a16z Bio+Health: a16z.com/bio-health
Stay Updated:
Find a16z Bio+Health on LinkedIn: linkedin.com/showcase/a16z-bio-health
Find a16z Bio+Health on X: https://x.com/a16zBioHealth
Subscribe on your favorite podcast app: a16z.com/podcasts/raising-health
Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
